OXYGENTA PHARMACEUTICAL
Back to Cashflow Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹2.60 Cr | ₹-13 Cr | ₹-1.63 Cr | ₹-1.68 Cr | ₹-1.62 Cr |
What is the latest Cash Flow from Operating Activities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹2.60 Cr |
| Mar2024 | ₹-13 Cr |
| Mar2023 | ₹-1.63 Cr |
| Mar2022 | ₹-1.68 Cr |
| Mar2021 | ₹-1.62 Cr |
How is Cash Flow from Operating Activities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.60 Cr | Positive | |
| Mar2024 | ₹-13 Cr | Negative | |
| Mar2023 | ₹-1.63 Cr | Negative | |
| Mar2022 | ₹-1.68 Cr | Negative | |
| Mar2021 | ₹-1.62 Cr | - | |
Compare Cash Flow from Operating Activities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹183.2 Cr | -0.7% | -11.7% | -48.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,938.0 Cr | -0.6% | -3.7% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 2.8% | 0.7% | -0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,385.0 Cr | 2.4% | 2.1% | 40.8% | Stock Analytics | |
| CIPLA | ₹111,220.0 Cr | 0.1% | 2.2% | -5.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,899.0 Cr | 0.5% | -1.9% | 2.2% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -0.7% |
-11.7% |
-48.1% |
| SENSEX | -1% |
-5% |
-9.2% |
You may also like the below Video Courses